深度卷积神经网络辅助识别肝硬化患者临床显著门静脉高压
研究纳入肝硬化患者,以肝静脉压力梯度≥10 mm Hg定义为临床显著门静脉高压(CSPH),用深度卷积神经网络分析CT或MR的肝脾图像识别CSPH。CT队列测试集AUC为0.933(95%CI 0.883-0.984),MR队列测试集AUC为0.940(95%CI 0.880-0.999),重复6次建模AUC均≥0.888。
要点
- 深度CNN分析CT或MR肝脾图像可无创识别肝硬化患者的CSPH。
- CT队列测试集AUC 0.933,MR队列测试集AUC 0.940。
- 重复6次建模AUC均≥0.888,轮次间无显著差异(P > .05)。
核心结论
- 深度CNN分析肝硬化患者CT或MR的肝脾图像,可识别CSPH,AUC约0.9,提供无创快速检测方法。
研究设计与样本
- 收集接受增强CT或MR检查、并在14天内行经颈静脉肝静脉压力梯度测定的肝硬化患者肝脾图像。
- CT队列来自CHESS1701研究,中国4家大学医院,2016年8月至2017年9月。
- MR队列来自CHESS1802研究,中国8家及土耳其1家大学医院,2018年12月至2019年4月。
- CT队列分析679例参与者的10,014张肝脏和899张脾脏图像;MR队列分析271例参与者的45,554张肝脏和脾脏图像。
- 每个队列将参与者随机等概率重复抽样6次,按3:1:1分为训练、验证和测试集,每个队列共建立6个深度CNN模型。
主要发现
- CT队列CNN识别CSPH的AUC:训练集0.998(95%CI 0.996-1.000),验证集0.912(95%CI 0.854-0.971),测试集0.933(95%CI 0.883-0.984)。
- MR队列CNN识别CSPH的AUC:训练集1.000(95%CI 0.999-1.000),验证集0.924(95%CI 0.833-1.000),测试集0.940(95%CI 0.880-0.999)。
- 模型建立过程重复6次,所有CNN分析的AUC均≥0.888,轮次间无显著差异(P > .05)。
关键数值与推荐
- CSPH定义为肝静脉压力梯度≥10 mm Hg。
- 图像采集需为肝静脉压力梯度测定前14天内的增强CT或MR检查。
临床怎么用
- 对肝硬化患者,可尝试用深度CNN分析其CT或MR肝脾图像,无创、快速地提示是否存在CSPH。
- 解读结果时应结合临床,注意模型来自特定多中心队列,尚未在常规临床流程中验证。
局限性
- 研究为模型开发与内部验证,未见外部独立人群验证的报道。
- 原文未报告患者排除标准、图像采集参数及模型可解释性等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Noninvasive and accurate methods are needed to identify patients with clinically significant portal hypertension (CSPH). We investigated the ability of deep convolutional neural network (CNN) analysis of computed tomography (CT) or magnetic resonance (MR) to identify patients with CSPH. METHODS: We collected liver and spleen images from patients who underwent contrast-enhanced CT or MR analysis within 14 days of transjugular catheterization for hepatic venous pressure gradient measurement. The CT cohort comprised participants with cirrhosis in the CHESS1701 study, performed at 4 university hospitals in China from August 2016 through September 2017. The MR cohort comprised participants with cirrhosis in the CHESS1802 study, performed at 8 university hospitals in China and 1 in Turkey from December 2018 through April 2019. Patients with CSPH were identified as those with a hepatic venous pressure gradient of 10 mm Hg or higher. In total, we analyzed 10,014 liver images and 899 spleen images collected from 679 participants who underwent CT analysis, and 45,554 liver and spleen images from 271 participants who underwent MR analysis. For each cohort, participants were shuffled and then sampled randomly and equiprobably for 6 times into training, validation, and test data sets (ratio, 3:1:1). Therefore, a total of 6 deep CNN models for each cohort were developed for identification of CSPH. RESULTS: The CT-based CNN analysis identified patients with CSPH with an area under the receiver operating characteristic curve (AUC) value of 0.998 in the training set (95% CI, 0.996-1.000), an AUC of 0.912 in the validation set (95% CI, 0.854-0.971), and an AUC of 0.933 (95% CI, 0.883-0.984) in the test data sets. The MR-based CNN analysis identified patients with CSPH with an AUC of 1.000 in the training set (95% CI, 0.999-1.000), an AUC of 0.924 in the validation set (95% CI, 0.833-1.000), and an AUC of 0.940 in the test data set (95% CI, 0.880-0.999). When the model development procedures were repeated 6 times, AUC values for all CNN analyses were 0.888 or greater, with no significant differences between rounds (P > .05). CONCLUSIONS: We developed a deep CNN to analyze CT or MR images of liver and spleen from patients with cirrhosis that identifies patients with CSPH with an AUC value of 0.9. This provides a noninvasive and rapid method for detection of CSPH (ClincialTrials.gov numbers: NCT03138915 and NCT03766880).
引用
- Liu Y, Ning Z, Örmeci N, et al. Deep Convolutional Neural Network-Aided Detection of Portal Hypertension in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020. PMID: 32205218. doi:10.1016/j.cgh.2020.03.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。